Theriva Biologics, Inc. (TOVX)
0.238
-0.01
(-3.88%)
USD |
NYAM |
Sep 14, 11:31
Theriva Biologics Net Income (Quarterly) : -3.217M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.217M |
| March 31, 2026 | -2.044M |
| December 31, 2025 | -1.996M |
| September 30, 2025 | -4.361M |
| June 30, 2025 | -13.06M |
| March 31, 2025 | -4.324M |
| December 31, 2024 | -4.447M |
| September 30, 2024 | -7.726M |
| June 30, 2024 | -8.316M |
| March 31, 2024 | -5.165M |
| December 31, 2023 | -5.485M |
| September 30, 2023 | -3.303M |
| June 30, 2023 | -5.084M |
| March 31, 2023 | -4.478M |
| December 31, 2022 | -5.591M |
| September 30, 2022 | -4.83M |
| June 30, 2022 | -4.477M |
| March 31, 2022 | -4.273M |
| December 31, 2021 | -5.263M |
| September 30, 2021 | -3.273M |
| June 30, 2021 | -3.195M |
| March 31, 2021 | -2.537M |
| December 31, 2020 | -2.132M |
| September 30, 2020 | -2.111M |
| June 30, 2020 | -2.883M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.99M |
| December 31, 2019 | -3.144M |
| September 30, 2019 | -5.15M |
| June 30, 2019 | -3.558M |
| March 31, 2019 | -3.528M |
| December 31, 2018 | -3.192M |
| September 30, 2018 | -3.689M |
| June 30, 2018 | -4.214M |
| March 31, 2018 | -2.326M |
| December 31, 2017 | 2.812M |
| September 30, 2017 | -10.93M |
| June 30, 2017 | -4.315M |
| March 31, 2017 | -3.058M |
| December 31, 2016 | -2.472M |
| September 30, 2016 | -8.489M |
| June 30, 2016 | -5.764M |
| March 31, 2016 | -11.08M |
| December 31, 2015 | -11.30M |
| September 30, 2015 | -7.507M |
| June 30, 2015 | -13.62M |
| March 31, 2015 | -12.36M |
| December 31, 2014 | -6.48M |
| September 30, 2014 | -4.91M |
| June 30, 2014 | -4.556M |
| March 31, 2014 | -3.838M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 51.29M |
| Yarrow Bioscience, Inc. | -2.899M |
| Nkarta, Inc. | -40.37M |
| Unicycive Therapeutics, Inc. | -1.722M |
| OnKure Therapeutics, Inc. | -15.35M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.217M |
| EPS Diluted (Quarterly) | -0.0701 |
| Enterprise Value | 3.579M |
| Earnings Yield | -281.0% |
| Normalized Earnings Yield | -287.18 |